Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Lingvay, I., Deanfield, J., Kahn, S
S.KimH.et al (2020)
The decision about treatment duration should be made collaboratively between patient and physician, considering individual response, tolerability, cost, insurance coverage, and personal goals
Editorial on editorial: Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity
[Micronutrients in oncology
These characteristics make it valuable for receptor-binding and hormone pathway research models
US$ 21.02
US$ 24.04
US$ 26.50
